1. Home
  2. STEX vs TOI Comparison

STEX vs TOI Comparison

Compare STEX & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STEX

Streamex Corp.

N/A

Current Price

$2.45

Market Cap

297.8M

Sector

N/A

ML Signal

N/A

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$2.45

Market Cap

327.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEX
TOI
Founded
2009
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.8M
327.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STEX
TOI
Price
$2.45
$2.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$12.00
$6.00
AVG Volume (30 Days)
2.9M
1.9M
Earning Date
03-30-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,000.00
$461,039,000.00
Revenue This Year
N/A
$28.51
Revenue Next Year
N/A
$25.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.67
52 Week Low
$0.40
$0.60
52 Week High
$14.11
$4.88

Technical Indicators

Market Signals
Indicator
STEX
TOI
Relative Strength Index (RSI) 33.42 35.46
Support Level $2.40 $2.48
Resistance Level $3.40 $2.87
Average True Range (ATR) 0.45 0.23
MACD -0.09 -0.02
Stochastic Oscillator 0.63 20.88

Price Performance

Historical Comparison
STEX
TOI

About STEX Streamex Corp.

Streamex Corp is a vertically integrated technology and infrastructure company. It is focused on the tokenization and digitalization of real-world assets. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Share on Social Networks: